• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

枸橼酸铋钾(CBS,得乐)的药理特性。

Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL).

作者信息

Wieriks J, Hespe W, Jaitly K D, Koekkoek P H, Lavy U

出版信息

Scand J Gastroenterol Suppl. 1982;80:11-6.

PMID:6962539
Abstract

In pharmacological ulcer models in rats colloidal bismuth subcitrate (CBS) demonstrated anti-ulcer activity. This was neither a result of an acid neutralizing nor of an acid secretion inhibitory effect. Both in vitro and in vivo, an anti-peptic action was found. At low pH CBS precipitates and was shown to form a coating on the gastric wall especially on the ulcer crater. This coating most likely forms a protective barrier to the peptic activity of gastric juice. Low toxicity was seen following chronic daily administration of high doses of CBS for 3 months to rats and 6 months to dogs. Although the blood levels were more elevated in rats, the tissue bismuth levels were comparable in the two species (except for the caecum). The chief bismuth-excreting organs, the kidneys, showed relatively high concentrations, while the brain-concentrations were extremely low in concordance with the absence of nervous system toxicity.

摘要

在大鼠的药理学溃疡模型中,枸橼酸铋钾(CBS)表现出抗溃疡活性。这既不是酸中和作用的结果,也不是胃酸分泌抑制作用的结果。在体外和体内均发现了抗胃蛋白酶作用。在低pH值下,CBS会沉淀,并在胃壁尤其是溃疡 crater 上形成一层涂层。这种涂层很可能对胃液的胃蛋白酶活性形成一种保护屏障。对大鼠连续3个月、对狗连续6个月每日给予高剂量CBS后,观察到低毒性。尽管大鼠的血铋水平升高得更多,但两种动物的组织铋水平相当(盲肠除外)。主要的铋排泄器官肾脏显示出相对较高的浓度,而脑浓度极低,这与无神经系统毒性一致。

相似文献

1
Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL).枸橼酸铋钾(CBS,得乐)的药理特性。
Scand J Gastroenterol Suppl. 1982;80:11-6.
2
A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid.枸橼酸铋钾的一种潜在作用机制:对盐酸的扩散屏障。
Scand J Gastroenterol Suppl. 1982;80:17-21.
3
Colloidal bismuth subcitrate inhibits peptic degradation of gastric mucus and epidermal growth factor in vitro.枸橼酸铋钾在体外可抑制胃黏液和表皮生长因子的消化降解。
Am J Gastroenterol. 1990 Apr;85(4):390-3.
4
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.枸橼酸铋钾。对其药效学和药代动力学特性及其在消化性溃疡疾病中的治疗应用的综述。
Drugs. 1988 Aug;36(2):132-57. doi: 10.2165/00003495-198836020-00002.
5
Gastric mucosa protective effects of colloidal bismuth subcitrate (DE-NOL).枸橼酸铋钾(得乐)对胃黏膜的保护作用。
Int J Tissue React. 1987;9(5):427-32.
6
Anti-ulcer activity of colloidal bismuth subcitrate in Shay-rats.
Arch Int Pharmacodyn Ther. 1976 Dec;224(2):291-8.
7
Biochemical response to colloidal bismuth subcitrate: dose-time effect.对枸橼酸铋胶体的生化反应:剂量-时间效应
Biol Trace Elem Res. 2005 Summer;105(1-3):151-8. doi: 10.1385/BTER:105:1-3:151.
8
Structure of colloidal bismuth subcitrate (CBS) in dilute HCl: unique assembly of bismuth citrate dinuclear units ([Bi(cit)(2)Bi](2-)).枸橼酸铋钾(CBS)在稀盐酸中的结构:柠檬酸铋双核单元([Bi(cit)(2)Bi](2-))的独特组装
J Am Chem Soc. 2003 Oct 15;125(41):12408-9. doi: 10.1021/ja037019x.
9
Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa.枸橼酸铋钾可诱导大鼠胃黏膜产生适应性细胞保护作用。
Acta Med Hung. 1991;48(3-4):197-201.
10
Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease.
Am J Gastroenterol. 1989 May;84(5):506-10.

引用本文的文献

1
A Short Review on Biomedical Applications of Nanostructured Bismuth Oxide and Related Nanomaterials.纳米结构氧化铋及相关纳米材料的生物医学应用综述
Materials (Basel). 2020 Nov 19;13(22):5234. doi: 10.3390/ma13225234.
2
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.如何有效使用铋剂四联疗法:优点、缺点与问题
Gastroenterol Clin North Am. 2015 Sep;44(3):537-63. doi: 10.1016/j.gtc.2015.05.003. Epub 2015 Jun 19.
3
Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity.
铋化合物的化学结构决定了它们的胃溃疡愈合功效和抗幽门螺杆菌活性。
Dig Dis Sci. 1998 Dec;43(12):2727-32. doi: 10.1023/a:1026667714603.
4
Mucosal coating agents and other nonantisecretory agents. Are they cytoprotective?
Dig Dis Sci. 1987 Jun;32(6):647-54. doi: 10.1007/BF01296166.
5
Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.枸橼酸铋钾(得乐)和硫糖铝的胃细胞保护作用。内源性前列腺素的作用。
Gut. 1987 Feb;28(2):201-5. doi: 10.1136/gut.28.2.201.
6
Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).胶体次枸橼酸铋(得乐)治疗前后胃及十二指肠溃疡患者的胃酸、胃蛋白酶和黏液分泌情况
Gut. 1986 May;27(5):486-90. doi: 10.1136/gut.27.5.486.
7
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.枸橼酸铋钾。对其药效学和药代动力学特性及其在消化性溃疡疾病中的治疗应用的综述。
Drugs. 1988 Aug;36(2):132-57. doi: 10.2165/00003495-198836020-00002.
8
Effect of bismuth subcitrate on amphibian gastroduodenal bicarbonate secretion.枸橼酸铋对两栖类动物胃十二指肠碳酸氢盐分泌的影响。
Gut. 1989 Jul;30(7):917-21. doi: 10.1136/gut.30.7.917.
9
Pharmacokinetics and toxicity of bismuth compounds.铋化合物的药代动力学与毒性
Med Toxicol Adverse Drug Exp. 1989 Sep-Oct;4(5):303-23. doi: 10.1007/BF03259915.
10
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).用于治疗胃肠道疾病的药物的临床药代动力学(第二部分)。
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.